As can be seen from the figure, AKT Serine/Threonine Kinase 1 (AKT1), Tumor Necrosis Factor (TNF), Solute Carrier Family 6 Member 4 and 3 (SLC6A4, SLC6A3), epidermal growth factor receptor (EGFR), Estrogen receptor 1 (ESR1), Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1), Cyclin D1 (CCND1), Dopamine Receptor D2 (DRD2), and Mechanistic Target of Rapamycin Kinase (MTOR) may be the key targets of S-W in the treatment of anxiety disorders. Here, DRD2 is linked to anxiety disorder.